Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,098,172
+$658,801 QoQ
Shares Held
211,723
-9.8% QoQ
Ownership
0.314%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 183 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. DNA ranks #115 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in DNA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,098,172 | 211,723 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,439,371 | 234,808 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,174,775 | 261,706 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,078,434 | 211,141 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,797,805 | 159,805 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $533,998 | 93,684 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $260,760 | 26,554 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $217,718 | 26,714 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $362,640 | 1,085,750 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,575,696 | 2,220,429 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,566,498 | 1,518,639 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,580,704 | 1,425,804 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,628,623 | 1,413,239 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,682,637 | 1,265,141 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,132,277 | 669,987 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,713,765 | 549,284 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,419,964 | 596,624 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||